Science

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center/LinkedIn

Jan 7, 2025, 14:28

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center shared a post on LinkedIn about a recent paper by Michael Weisman et al. published in International Journal of Radiation Oncology, Biology, Physics:

“Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer”

Authors: Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser Hanna, Sandra Althouse, Tim Lautenschlaeger.

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC - IU Simon Comprehensive Cancer Center

“Gain valuable insights from a new article published in the International Journal of Radiation Oncology, Biology, Physics by the cancer center’s Greg Durm, MD, Misty D. Shields, MD, PhD, Nasser H. Hanna, MD, Tim Lautenschlaeger, MD, and colleagues.”

More posts featuring IU Simon Comprehensive Cancer Center.

cancer Greg Durm ipilimumab IU Simon Comprehensive Cancer Center Michael Weisman Misty Dawn Shields Nasser Hanna nivolumab non small cell lung cancer NSCLC OncoDaily Oncology Sandra Althouse Tim Lautenschlaeger

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action